The joint GenomeWeb/Bank of America survey showed that most respondents had one preferred supplier despite the prevalence of a multitude of online catalogs.
CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.
The CSIRO researchers are collaborating to validate their results and determine the effects of epigenetics on CRISPR gRNA effectiveness.
Edico will make its Dragen platform available on new Amazon cloud instances, allowing users to scale up analysis capacity as demand for computing resources grows.
Couples can now buy cystic fibrosis and spinal muscular atrophy carrier screening tests through Amazon, though a doctor will have to approve the order.
Amazon's infrastructure will support AHA-funded research into genetic, environmental, and lifestyle factors that affect cardiovascular health.
The Genome Analysis Toolkit is available on the Google cloud and will be launched on Amazon, Microsoft, and IBM's clouds and BaseSpace later this year.
The developers are offering free single analysis codes to use Nephele as part of a promotion to test the features and feasibility of the system.
The company is putting finishing touches on new cloud-based applications for metagenomics and oncology that it could launch as early as next year.
Amazon and Google are striving to be researchers' go-to service for genomic data storage and analysis, Reuters reports.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.